ID: ALA4778163

Max Phase: Preclinical

Molecular Formula: C18H26O3

Molecular Weight: 290.40

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCC/C=C/c1cccc(C(=O)O)c1O

Standard InChI:  InChI=1S/C18H26O3/c1-2-3-4-5-6-7-8-9-10-12-15-13-11-14-16(17(15)19)18(20)21/h10-14,19H,2-9H2,1H3,(H,20,21)/b12-10+

Standard InChI Key:  GGDVKLHHXIVMSC-ZRDIBKRKSA-N

Associated Targets(Human)

Small ubiquitin-related modifier 1 633 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 290.40Molecular Weight (Monoisotopic): 290.1882AlogP: 5.24#Rotatable Bonds: 10
Polar Surface Area: 57.53Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 2.74CX Basic pKa: CX LogP: 6.66CX LogD: 3.16
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.58Np Likeness Score: 0.89

References

1. Brackett CM,García-Casas A,Castillo-Lluva S,Blagg BSJ.  (2020)  Synthesis and Evaluation of Ginkgolic Acid Derivatives as SUMOylation Inhibitors.,  11  (11): [PMID:33214832] [10.1021/acsmedchemlett.0c00353]

Source